Gefitinib in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer or Primary Peritoneal Cancer

NCT00023699 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

NETWORK

Sponsor class

Conditions

Ovarian Cancer
Primary Peritoneal Cavity Cancer

Interventions

DRUG: gefitinib

Sponsor

Gynecologic Oncology Group

Collaborators

[object Object]